title: Symptomatic hypocalcemia due to oral risedronate therapy.
authors.forename: Teoman
authors.initials: T
authors.lastname: Dogru
authors.forename: A
authors.initials: A
authors.lastname: Sonmez
authors.forename: I
authors.initials: I
authors.lastname: Tasci
authors.forename: H
authors.initials: H
authors.lastname: Genc
mesh_terms: D000328:Adult; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D002446:Celiac Disease / Q000150:complications / Q000188:drug therapy; D012968:Etidronic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced*; D008297:Male; D010024:Osteoporosis / Q000188:drug therapy / Q000209:etiology; D000068296:Risedronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D000068296:Risedronic Acid; D012968:Etidronic Acid